| Literature DB >> 20971004 |
Thomas J Woltering1, Jürgen Wichmann, Erwin Goetschi, Frédéric Knoflach, Theresa M Ballard, Jörg Huwyler, Silvia Gatti.
Abstract
This study completes a series of papers devoted to the characterization of the non-competitive mGluR2/3 antagonist properties of 1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives with particular emphasis on derivatizations compatible with brain penetration and in vivo activity. Especially the compounds bearing a para-pyridine consistently showed in vivo activity in rat behavioral models after oral administration, for example, blockade of the mGluR2/3 agonist LY354740-induced hypoactivity and improvement of a working memory deficit induced either by LY354740 or scopolamine in the delayed match to position task (DMTP). Moreover, combination studies with a cholinesterase inhibitor show apparent synergistic effects on working memory impairment induced by scopolamine.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20971004 DOI: 10.1016/j.bmcl.2010.09.125
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823